Twenty-five patients with proven pulmonary emboli were followed for at least 20 weeks with serial scans and, in select cases, angiograms to determine the factors influencing the rate of resolution. Fifteen patients showed complete resolution at some time during the observation period. Five of these 15 patients experienced recurrent embolic episodes either before or after complete resolution. The remaining 10 patients included two who died of recurrent massive emboli, three who had recurrent episodes resulting in incomplete resolution, two who showed incomplete resolution at 20 weeks without recurrent emboli, and three who were lost to follow-up.
boli over a period of time ranging from 1 week to several months in the majority of patients. [1] [2] [3] [4] [5] Scanning has been employed as the primary technique for delineating the course of pulmonary emboli in other studies. 6 7 Most of the observations in the above studies consist of an initial and one subsequent observation. This study was designed to utilize both angiography and scanning for diagnosis and serial study of patients with pulmonary emboli.
Methods
Pulmonary emboli in 25 patients (four females and 21 males) were observed by use of 34 angiograms and 98 scans. The average age of the patients was 60 years; they were observed for a minimal time of 20 weeks following the initial pulmonary embolus. The initial diagnostic studies were carried out as soon as possible, averaging had postoperative, postpartum, or post-traumatic emboli; the remaining 15 were hospitalized for various medical illnesses. Thrombophlebitis was evident in three of the former group and in 10 of the latter group. Heart disease was present in three of the first group and in four of the second group. Only those patients having positive findings on lung scans and with major vascular obstruction verified by pulmonary angiography were accepted in this study.
Administration of heparin was employed routinely, with an average treatment of 14.7 days for the initial embolic episode. Eleven patients subsequently received anticoagulants by mouth for varying periods. Four patients had plication of the inferior vena cava. Individual treatment is outlined in table 1. Right heart catheterization and angiography were performed in the usual manner, with the preferred injection site being the proximal pulmonary artery. Repeat angiograms were used primarily to aid in the interpretation of persistently abnormal lung scans.
For the lung scans 150 to 250 uc of macroaggregated, radioiodinated albumin and a Picker Magna V scanner* having a 5 X 2-inch sodium *Picker Nuclear, White Plains, New York. DETERiMINATION OF iodide thallium-activated scintillation detector and a 5-inch broad focus, 85-hole lead collimator were used. The detector was moved at a linear speed of 80 to 100 cm/min. Multiple views were obtained in the majority of patients, with lateral scans in six cases. Sixty-four of 98 scans obtained were performed within the first 4 weeks of observation. The degree of resolution was determined principally by follow-up scan. Studies were repeated, when possible, at weekly intervals for the first 4 weeks and at indefinite periods thereafter, depending on the individual patients. The term "resolution" is used throughout this study to imply restoration of blood flow within the embolized pulmonary vascular bed. Furthermore, the terms "complete" and incomplete" resolution are used with the recognition of the limitations of the techniques used.
The determination of the extent of embolization was made by a visual estimate of the field defect. A field defect was defined as that area of the lung fields which showed absence or relative absence of radioactivity on the lung scan. The field defect as defined does not infer the quantitation of regional pulmonary blood flow but, rather, the demarcation of a relative anatomic Diagrammatic representation of the methods used in estimating the initial field defect and the percentage of resolution. Each lung field is estimated as a whole, then the initial field defect is determined as shown on the left (40%). A follow-up scan (in a few instances an angiogram) is shown diagrammatically on the right, with calculation of the field defect (15%). The percentage of resolution in this example is, therefore, 62.5 as calculated at a given time interval. *Two values given during the same time interval represent chronological determinations of the field defect.
Abbreviations: L.T. = long-term anticoagulation, arbitrarily defined in this study as 6 mo or more; PO = postopera =benign prostatic hypertrophy; RHD _ rheumatic heart disease; MS = mitral stenosis; IVC = inferior vena cava; syphilitic heart disease; OHD = organic heart disease. I ; L area. Each lung field was judged as a whole, and the percentage of absence of radioactivity was noted, as shown in figure 1 . On the left is shown an initial study with the lung scan diagrammatically represented as the shaded area. Superimposed is the angiogram diagrammatically showing blockage. The initial field defect is estimated at 40%. On the right is shown diagrammatically a follow-up study at a given weekly interval, showing incomplete resolution with a field defect of 15%. The percent of resolution at this time interval would be 62.5 as illustrated. Two observers analyzed the data by this method. Analysis of scans was performed after return to nonnal or after maximum clearing in order to ap-preciate the full extent of the lung field. The estimates of the two observers were within 10% of each other in nearly all cases.
There was no mortality nor significant morbidity due to catheterization angiography, or scanning in this series of patients. Results
The initial hemodynamic data in t-his group of patients were comparable to those previously reported, 8 than pulmonary emboli to account for the pulmonary hypertension observed. Figure 2 shows a posterior scan of a representative patient with a large defect in the right lung field and a minimal lesion in the left lateral lung field. The defect in the right lung is estimated at 75% and in the left 5%, for an initial field defect of 40%. Figure 3 is an angiogram confirming these findings. Figure  4 shows a follow-up posterior scan at 2 weeks with incomplete clearing of the right side, leaving an estimated 20% defect. The defect on the left is unchanged at 5%, so the initial right lung field estimated at 75%, and in the left lung in figure 2, shows marked imprc field at 5%, with an initial field defect of 40%. lung field and no change in the veeks after the scan ovement in the right e left. The defect in the right lung field is estimated at 20% and in the left lung at 5%, for a field defect of 12.5%. Pulmonary angiogram showing occlusion of the right lower lobar artery, partial occlusion of the right middle lobar artery, and a suggestion of segmental arterial occlusion in the left lung field. field defect at 2 weeks is 12.5%. Since the initial defect was estimated at 40%, the percentage of resolution at 2 weeks would be 69%.
An attempt was made to determine the rate of resolution of pulmonary emboli by analyzing the percentage of resolution observed at weekly intervals with emphasis on the first 4 weeks. If a patient had a -recurrent embolus within the 4-week period, then observation fo-r resolution of that specific initial embolic episode was terminated. Recurrent episodes in six patients were included in this analysis when definite new areas of embolization occurred and resolution could be determined by the method outlined. Figure 5 observations made in the first 4 weeks after 31 episodes of embolization in 25 patients. It is important to note that the figure is corrected for the time of occurrence of embolization. For example, if a patient had symptoms for 1 week prior to the initial diagnostic study, the follow-up study done a week after the initial diagnostic study was considered to be the 2-week interval. The time of embolization was accurately obtained in 23 episodes but was less definite in the remaining eight, and an estimated date was established. The percentage of resolution ranged from 0 to 100% at 1 and 2 weeks, from 27% to 100% at 3 weeks, and from 33% to 100% at 4 weeks. The mean percentage of resolution was 63% at 1 week, 67% at 2 weeks, and 80% at 3 weeks and at 4 weeks. Hence there was a large variation in patient response with a trend toward resolution during the first 4 weeks of observation. Complete resolution occurred in 15 patients at some point during the 20-week period of observation (table 1). In five of these (nos. 11, 16, 18, 20, and 21), there were recurrent episodes either before or after complete resolution. The remaining 10 patients included two (nos. 17 and 22) who died of recurrent massive embolization, three (nos. 5, 10 and 25) with recurrent episodes resulting in incomplete resolution, two (nos. 14 and 24) who showed incomplete resolution at 20 weeks without recurrent emboli, and three (nos. 6, 8 and 19) who were lost to follow-up.
The latter three patients were known to be living past the 20-week observation period.
It should be emphasized that 10 patients had recurrent embolization during the time of observation. The diagnosis was established clinically and with lung scans in seven patients and at autopsy in three others. The magnitude of the recurrent emboli may not be appreciated from a perusal of the field defect in table 1 at the time of recurrence unless it is emphasized that resolution was rather marked in most patients, as shown in figure   5 . The figures given at the time of recurrence may represent new areas or combinations of old and new areas of embolization.
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Four patients (nos. 1, 6, 14 and 25) showed slow resolution as defined by less than 50% clearing of the initial field defect during the first 4 weeks of observation. These four patients accounted for seven of the nine repeat observations showing less than 50% resolution ( fig. 5 ).
Discussion
The restoration of pulmonary blood flow following pulmonary embolization began to occur promptly in the majority of patients observed. Four patients showed slow resolution as defined. The slow resolution observed in these four patients is in contrast to the others and affects adversely the mean percentage of resolution seen in figure 5 . The mean percentage of resolution at weekly intervals for all 25 patients, including observations on recurrent episodes in six patients, was 63%, 67%, 80% and 80%, as noted previously. Exclusion of the four patients with slow resolution reveals the mean percentage of resolution to be 79%, 73%, 87% and 93% at the first, second, third, and fourth weeks, respectively, and is representative of the usual course of an embolic episode observed in this series. Recurrent embolization to identical areas cannot be excluded as a cause of slow resolution, and more frequent scanning might be informative since resolution may be followed by embolization to the same area. The difference in rate of resolution may be related to the age of the embolized clot, as suggested from experimental work9-11 and may be a factor in the variation of the rate of resolution seen in this series. This group of 25 patients represents a wide range of pulmonary embolization, varying from 5% to 75% initial field defect with an average of 30.5%. This includes 10 patients with an extensive pulmonary embolus. Tow and Wagner6 found that the larger the initial lung field defect on lung scan, the less chance of complete recovery of blood flow. The present study confirms this finding and indicates that recurrent pulmonary embolization is the most important event affecting restoration of blood flow.
Size of Initial Field Defect
The extent of embolization as determined by the initial field defect was an important factor in the resolution of the initial embolic episode. Ten patients had initial field defects in excess of 35%, with an average of 49.2%. Seven of these had recurrent embolization, one showed incomplete resolution with documented changes on serial scan and angiogram, one was lost to follow-up unresolved, and the remaining patient was the only one to have a documented and uncomplicated complete resolution. Six patients (nos. 17 and 21 to 25) of the 10 with initial field defects of over 35% manifested clinical shock of varying severity. The two patients with the largest field defects were seriously considered for surgical intervention prior to stabilization of vital signs following prompt medical therapy.
Clinical shock identified the patients with an extensive embolic episode except for two patients (nos. 13 and 15) who had predisposing factors to shock as noted in table 1. Both had initial field defects due to embolization of less than 35%, and in both resolution was prompt.
In 10 of the 25 patients in this series resolution occurred without complication; these 10 patients had an average field defect of 20.5%. In comparison, the 10 patients with recurrent episodes had an average initial field defect of 38.2%.
Heart Disease
Five of seven patients with heart disease had recurrence of embolization. Three of the five deaths in this series were in patients with heart disease, and in two patients, recurrent embolization was the immediate cause of death. Chait and associates3 reported the adverse effect of heart disease on resolution and observed recurrent embolization in a significant number of patients studied.
Thrombophlebitis
The presence of peripheral thrombophlebitis and pulmonary embolization as the only disease process indicates the need for close observation. Six patients in this series were in this category. Three of these six patients (nos. 10, 18 , and 20) had recurrent emboliza-tion in the absence of recognizable predisposing factors; one (no. 14) showed slow resolution, one (no. 4) prompt resolution, and in one (no. 8) resolution had not occurred when the patient was lost to follow-up.
Thrombophlebitis and pulmonary embolization associated with other diseases have a varied course, and the prognosis may depend on the associated disease.
Iecurrent Pulmonary Embolization
Recurrent embolization was found in 10 patients within a 20-week period of observation. These 10 patients received heparin an average of 16.1 days for the initial embolic episode. Heparin therapy was complicated with gross bleeding in four of these patients at 2, 8, 11 , and 13 days after initiation of therapy, and it was necessary to discontinue treatment. A longer period of heparin therapy was not effective in preventing further embolization in the remaining six patients, whose average treatment period was 21.1 days for the initial embolic episode. The oral administration of anticoagulants following heparin therapy was dependent upon the discretion of the physician in charge. Four of the 10 patients with recurrent emboli received anticoagulants by mouth for varying periods, in comparison to seven of 15 patients who received them following heparin and who did not experience recurrent embolization.
Recurrent emboli during treatment with heparin was uncommon, and was clearly documented in only two patients (nos. 16 and 25) . One of these was inadequately anticoagulated because of troublesome bleeding. Documentation of recurrence in the remaining eight patients followed cessation of anticoagulant therapy and varied from I to 15 weeks, with a mean of 5.8 weeks.
Silent recurrent pulmonary embolization was documented by serial study in three patients. One patient (no. 5) was fully ambulatory for a time while demonstrating recurrence, a second patient (no. 16) was at first mentally confused but at the time of recurrence was alert, and the third patient (no. 21) had paraplegia with hyposthesia from the Circulation, Volume XXXVIIF, December 1968 fifth thoracic level, distally. It is conceivable that the latter two patients had disabilities which might have altered their appreciation of symptoms of recurrent pulmonary embolism. These three patients would not have been diagnosed as having recurrent emboli without serial scans.
Four patients had plication of the inferior vena cava following recurrent embolization. Recurrent pulmonary emboli occurred in one patient following ligation, but the inferior vena cavogram was normal. A plastic clip had been used in this patient.
Three patients had three distinct episodes each of recurrent embolization during the observation period. Two of these (nos. 5 and 21) received no further anticoagulants after hemorrhagic complications developed at 2 and 13 days respectively. Patient 5 refused further therapy and patient 21 was not treated after the initial therapy because of his fatal underlying disease and asymptomatic recurrence. Autopsy revealed no evidence of pulmonary emboli in this patient. The third patient (no. 25) represented a therapeutic failure because of recurrent emboli while receiving heparin and after inadequate inferior vena caval plication as previously mentioned. Embolization recurred despite continued use of oral anticoagulants, and the patient refused further surgical therapy.
Recurrent embolization was, therefore, documented by serial scans in 40%o of these patients followed for at least 20 weeks or until death. Although recurrence was uncommon during adequate anticoagulant therapy, it was noted occasionally in the absence of symptoms, and when embolization recurred at least three times, inadequate therapy was a factor. The recurrence rate is high in this series because of serial scanning and careful postmortem examination. Barker and Priestley12 found a 30% recurrence rate prior to application of present techniques. Emboli were found at postmortem examination in 64% of cases in one necropsy study.'3 Smith and associates'4 showed that many patients with pulmonary emboli had evidence at autopsy of emboli in various stages of resolu-Circulation, Volume XXXVIII, December 1968 tion, emphasizing the recurrent nature of pulmonary embolic disease.
Prognosis and Therapy
This study reveals recurrent embolization to be the most significant factor adversely affecting the prompt and uncomplicated restoration of blood flow following pulmonary embolization. Pulmonary embolization is likely to be recurrent in the patient who presents with: (1) a large initial field defect (35% or greater as defined by the methods used), (2) associated heart disease, and (3) peripheral thrombophlebitis and pulmonary embolism without other disease. Multiple factors may be of importance in the pathogenesis of pulmonary embolic disease, but the severity of the problem may be represented by the proportion of the pulmonary vascular bed occluded at the time of the initial diagnosis. Heart disease is known to predispose to recurrent embolic episodes as was noted in clinical and postmortem data in this study. Whether patients with thrombophlebitis and pulmonary embolism without other disease warrant special attention as suggested in this study remains to be determined by future investigation.
If the patient who is most likely to have recurrent embolization can be identified, a more aggressive therapeutic program is indicated. The length of time of anticoagulation recommended is largely empirical, but recent reports'5-18 suggest continued therapy in the patient with pulmonary embolization for 3 to 12 months. Our data suggest that the patient most likely to have recurrent embolization can be identified and, based on the time of most likely recurrent embolization in this series, we suggest anticoagulation for at least 6 months.
